Get the App
A

Acrivon Therapeutics (ACRV)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Acrivon Therapeutics (ACRV)

Acrivon Therapeutics, Inc. is a United States-based is a clinical-stage oncology therapeutics company. The Company provides technologies driving precision-based medicine. It leverages its phosphoproteomics technology called Acrivon Precision Predicti... Read more

  • USD13.03
  • USD13.99
  • USD12.60
  • USD25.47
  • -15.10%
  • --
  • 28.53k
  • 159.43k
  • 272M
  • 10.90

Stock News

The Moneyist: ‘They do not trust her, nor do I’: My elderly parents fear my sister will empty their bank accounts and steal their possessions. What can we do?

1 hour ago

The Moneyist: ‘They do not trust her, nor do I’: My elderly parents fear my sister will empty their bank accounts and steal their possessions. What can we do?

MarketWatch

Cohen & Steers Closed-End Funds Declare Distributions for April, May, and June 2023

1 hour ago

Cohen & Steers Closed-End Funds Declare Distributions for April, May, and June 2023

Yahoo

Living With Climate Change: Wind damage will impact more U.S. homes than before, in Florida especially. How best to protect your property.

1 hour ago

Living With Climate Change: Wind damage will impact more U.S. homes than before, in Florida especially. How best to protect your property.

MarketWatch

PowerSchool Introduces International Localization Framework to Support Growing Global Customer Base

1 hour ago

PowerSchool Introduces International Localization Framework to Support Growing Global Customer Base

Yahoo

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium